Jilin Jian Yisheng Pharmaceutical Co., Ltd. (SHE:002566)
China
· Delayed Price · Currency is CNY 8.54
+0.15 (1.79%)
Mar 10, 2026, 3:04 PM CST
SHE:002566 Revenue
Jilin Jian Yisheng Pharmaceutical had revenue of 148.37M CNY in the quarter ending September 30, 2025, a decrease of -5.93%. This brings the company's revenue in the last twelve months to 639.10M, down -9.74% year-over-year. In the year 2024, Jilin Jian Yisheng Pharmaceutical had annual revenue of 668.47M, down -21.69%.
Revenue (ttm)
639.10M
Revenue Growth
-9.74%
P/S Ratio
4.42
Revenue / Employee
385.93K
Employees
1,656
Market Cap
2.83B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 668.47M | -185.20M | -21.69% |
| Dec 31, 2023 | 853.66M | 23.62M | 2.85% |
| Jan 1, 2023 | 830.04M | -47.89M | -5.45% |
| Jan 1, 2022 | 877.93M | 35.34M | 4.19% |
| Dec 31, 2020 | 842.59M | -170.16M | -16.80% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shandong Sito Bio-technology | 954.76M |
| Shanghai Universal Biotech | 1.07B |
| Jiangsu Sihuan Bioengineering | 341.90M |
| Novoprotein Scientific | 151.51M |
| Shanghai Serum Bio-Technology | 196.21M |
| Landfar Bio-medicine | 125.47M |
| Zhejiang East Asia Pharmaceutical | 831.56M |
| Suzhou Fushilai Pharmaceutical | 439.57M |